These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 28083070)
41. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Tillie-Leblond I; Pugin J; Marquette CH; Lamblin C; Saulnier F; Brichet A; Wallaert B; Tonnel AB; Gosset P Am J Respir Crit Care Med; 1999 Feb; 159(2):487-94. PubMed ID: 9927362 [TBL] [Abstract][Full Text] [Related]
42. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173 [TBL] [Abstract][Full Text] [Related]
43. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D). Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334 [TBL] [Abstract][Full Text] [Related]
45. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Isomäki P; Punnonen J Ann Med; 1997 Dec; 29(6):499-507. PubMed ID: 9562516 [TBL] [Abstract][Full Text] [Related]
46. Dysregulation of proinflammatory versus anti-inflammatory human T Noster R; de Koning HD; Maier E; Prelog M; Lainka E; Zielinski CE J Allergy Clin Immunol; 2016 Oct; 138(4):1161-1169.e6. PubMed ID: 27040374 [TBL] [Abstract][Full Text] [Related]
47. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661 [TBL] [Abstract][Full Text] [Related]
48. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. van Hogezand RA; Verspaget HW Scand J Gastroenterol Suppl; 1997; 223():105-7. PubMed ID: 9200315 [TBL] [Abstract][Full Text] [Related]